Viking Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share

August 10, 2016 7:08 AM EDT

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.22), versus ($1.07) reported last year.

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More